"Queen’s Cancer Center is your best choice for cancer care. Our comprehensive care program was established in Hawaii more than 40 years ago. Today, we continue to provide Hawaii’s patients with complete cancer care, from prevention to diagnosis and treatment, to survivorship. We offer cancer care in Honolulu, West Oahu and on Hawaii Island and provide a personalized, comprehensive approach to each patient’s unique diagnosis."

During the past decade, Queen's Cancer Center - Kuakini conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 49 clinical trials were completed, i.e. on average, 42.6% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 33 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's Cancer Center - Kuakini" #1 sponsor was "National Cancer Institute (NCI)" with 93 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's Cancer Center - Kuakini" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Queen's Cancer Center - Kuakini" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IVA Lung Cancer AJCC v8" (7 trials) and "Stage IVB Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Queen's Cancer Center - Kuakini" in a lesser frequency.

Most popular intervention types in "Queen's Cancer Center - Kuakini" are "Drug" (113 trials), "Other" (101 trials), "Biological" (63 trials), "Procedure" (43 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (48 trials), "Questionnaire Administration" (30 trials), "Computed Tomography" (24 trials) and "Biospecimen Collection" (22 trials). Other intervention names were less common.

The vast majority of trials in "Queen's Cancer Center - Kuakini" are 115 trials for "All" genders, 29 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Queen's Cancer Center - Kuakini". undefined are not yet recruiting, 41 are recruiting, 86 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Queen's Cancer Center - Kuakini, 6 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's Cancer Center - Kuakini, 5 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".